MTAP deletion increases dependence on protein arginine methyltransferase 5 (PRMT5) and inhibition of PRMT5 selectively kills MTAP-null cancer cells [125,126,127], indicating that inhibition of PRMT5 is a potential therapy for MTAP-deleted tumors. Here, PRMT5 is linked to cancer.